| Literature DB >> 28865344 |
Jonna B Westover1, Johanna D Rigas2, Arnaud J Van Wettere2, Rong Li1, Brady T Hickerson1, Kie-Hoon Jung1, Jinxin Miao3, Erin S Reynolds4, Bettina L Conrad5, Skot Nielson1, Yousuke Furuta6, Saravanan Thangamani4, Zhongde Wang1, Brian B Gowen7.
Abstract
Heartland virus (HRTV) is an emerging tick-borne virus (Bunyaviridae, Phlebovirus) that has caused sporadic cases of human disease in several central and mid-eastern states of America. Animal models of HRTV disease are needed to gain insights into viral pathogenesis and advancing antiviral drug development. Presence of clinical disease following HRTV challenge in hamsters deficient in STAT2 function underscores the important role played by type I interferon-induced antiviral responses. However, the recovery of most of the infected animals suggests that other mechanisms to control infection and limit disease offer substantial protection. The most prominent disease sign with HRTV infection in STAT2 knockout hamsters was dramatic weight loss with clinical laboratory and histopathology demonstrating acute inflammation in the spleen, lymph node, liver and lung. Finally, we show that HRTV disease in hamsters can be prevented by the use of favipiravir, a promising broad-spectrum antiviral in clinical development for the treatment of influenza.Entities:
Keywords: Animal model; Favipiravir; Heartland virus; Phlebovirus; Severe fever with thrombocytopenia syndrome virus; Type I interferon
Mesh:
Substances:
Year: 2017 PMID: 28865344 PMCID: PMC5623653 DOI: 10.1016/j.virol.2017.08.004
Source DB: PubMed Journal: Virology ISSN: 0042-6822 Impact factor: 3.616